Cellectis S.A.
ALCLS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | 5,397.5% | -96.1% | -74.1% | – |
| Cost of Goods Sold | €0 | €0 | €0 | €0 |
| Gross Profit | €0 | €0 | €0 | €0 |
| % Margin | 100% | 2.4% | 90.8% | 50.9% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | €0 | €0 | €0 |
| Sales & Mktg Exp. | €0 | -€0 | €0 | €0 |
| Other Operating Expenses | -€0 | -€0 | -€0 | -€0 |
| Operating Expenses | €0 | €0 | €0 | €0 |
| Operating Income | -€0 | -€0 | -€0 | -€0 |
| % Margin | -143.5% | -12,887.7% | -467.7% | -115.5% |
| Other Income/Exp. Net | €0 | -€0 | -€0 | €0 |
| Pre-Tax Income | -€0 | -€0 | -€0 | -€0 |
| Tax Expense | €0 | €0 | €0 | -€0 |
| Net Income | -€0 | -€0 | -€0 | -€0 |
| % Margin | -88.6% | -13,385.3% | -514.8% | -116.7% |
| EPS | -0.41 | -2.08 | -2.17 | -1.93 |
| % Growth | 80.3% | 4.1% | -12.4% | – |
| EPS Diluted | -0.41 | -1.92 | -2.17 | -1.93 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €0 | €0 | €0 | €0 |
| Depreciation & Amortization | €0 | €0 | €0 | €0 |
| EBITDA | -€0 | -€0 | -€0 | -€0 |
| % Margin | -22.8% | -12,269.7% | -398.4% | -115.5% |